Daxor Co. (NASDAQ:DXR) Sees Large Growth in Short Interest

Daxor Co. (NASDAQ:DXR) saw a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 6,600 shares, a growth of 13.8% from the May 15th total of 5,800 shares. Currently, 0.3% of the shares of the company are sold short. Based on an average daily volume of 2,300 shares, the days-to-cover ratio is currently 2.9 days.

Daxor Stock Up 1.7 %

Shares of DXR traded up $0.15 during mid-day trading on Friday, reaching $9.00. 270 shares of the stock traded hands, compared to its average volume of 1,112. Daxor has a 1 year low of $7.11 and a 1 year high of $10.15. The firm has a fifty day moving average price of $9.44 and a 200 day moving average price of $8.88.

Daxor Company Profile

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions.